ECVT Stock Analysis: Buy, Sell, or Hold?
ECVT - Ecovyst Inc.
$10.00
-0.45 (-4.26%)
▼
5d:
-3.8%
30d:
-19.78%
90d:
-27.62%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Get Alerted When ECVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ECVT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ECVT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.01
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$16.77
40.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ECVT is currently trading at $9.99, which is considered oversold relative to its 30-day fair value range of $10.32 to $12.49. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.0) compared to its historical average (15.9). Remarkably, the market is currently pricing in an annual earnings decline of 9.0% over the next few years. This pessimistic expectation contrasts with the company's recent 48.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, ECVT is in a strong uptrend. The price is currently testing key support at $9.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: ECVT scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.50 (+48.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ECVT is in a strong uptrend. The price is currently testing key support at $9.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.3% recently.
Market Sentiment: ECVT scores 92/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $15.50 (+48.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.32 -
$12.49
Company Quality Score
75/100
(STRONG BUY)
Volume Confirmation
HIGH
Confidence Score
85.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (92/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.3%)
- BULLISH: Trading 48.5% below Wall St target ($15.50)
- CAUTION: Bottoming setup, but lagging the sector by 17% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$10.32 -
$12.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.91
Resistance Level
$10.73
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.97
Wall Street Target
$15.50
(+48.5%)
Revenue Growth (YoY)
42.0%
Earnings Growth (YoY)
48.9%
Profit Margin
-7.1%
Valuation Discount vs History
-9.0% cheaper
PE vs Historical
12.0 vs 15.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.0%
(market-implied from PE analysis)
1-Year Target
$9.50
(-9%)
2-Year Target
$8.65
(-17%)
3-Year Target
$7.87
(-25%)
3-Yr Target (if PE normalizes)
(PE: 12→16)
$10.45
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 27.5%)
$36.29
(+248%)
Base:
(SPY PE: 12.0, Growth: 27.5%)
$21.65
(+107%)
Bear:
(PE: 10.2, Growth: 27.5%)
$18.40
(+76%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (45x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 44.87 | Current EPS (TTM): $0.23
Bull Case
$22.70
(+118%)
Analyst growth 100.0%, PE expands to 49.4
Base Case
$20.64
(+98%)
Market implied 100.0%, PE stable at 44.9
Bear Case
$7.02
(-33%)
Severe decline -20.0%, PE contracts to 38.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.0 to 15.9
Stabilization Target:
$13.87
(+32.8%)
PE Expansion Potential:
+32.8%
Share & Embed Analysis
Last updated: August 24, 2026 12:55 PM ET
Data refreshes hourly during market hours. Next update: 1:55 PM
Data refreshes hourly during market hours. Next update: 1:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ECVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Specialty Chemicals Stocks
Top-rated stocks in Specialty Chemicals by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LIN
Linde plc Ordinary Shares |
BUY
28 analysts |
$547 | 67 BUY |
|
ECL
Ecolab Inc |
STRONG BUY
27 analysts |
$325 | 48 HOLD |
|
SHW
Sherwin-Williams Co |
BUY
28 analysts |
$391 | 43 HOLD |
|
APD
Air Products and Chemica… |
BUY
24 analysts |
$344 | 49 HOLD |
|
DD
Dupont De Nemours Inc |
STRONG BUY
16 analysts |
$170 | 55 HOLD |
